X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7) 7
humans (6) 6
cardiac & cardiovascular systems (5) 5
female (5) 5
male (5) 5
cholesterol (4) 4
density-lipoprotein cholesterol (4) 4
middle aged (4) 4
risk factors (4) 4
triglycerides (4) 4
aged (3) 3
coronary-heart-disease (3) 3
europe - epidemiology (3) 3
prevention (3) 3
therapy (3) 3
3121 internal medicine (2) 2
acute myocardial-infarction (2) 2
all-cause mortality (2) 2
anticholesteremic agents - adverse effects (2) 2
apolipoprotein b (2) 2
apolipoprotein c-iii (2) 2
canada - epidemiology (2) 2
cardiovascular disease (2) 2
cardiovascular diseases - epidemiology (2) 2
cholesterol, hdl - blood (2) 2
cholesterol, hdl - drug effects (2) 2
cholesterol, ldl - blood (2) 2
combination lipid therapy (2) 2
cross-sectional studies (2) 2
double-blind method (2) 2
dyslipidaemias (2) 2
dyslipidemias - epidemiology (2) 2
endocrinology & metabolism (2) 2
guidelines (2) 2
high-density lipoproteins (2) 2
high-dose atorvastatin (2) 2
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (2) 2
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2) 2
hypercholesterolemia - drug therapy (2) 2
lipoprotein remnants (2) 2
low hdl-cholesterol (2) 2
low-density lipoproteins (2) 2
lowering ldl cholesterol (2) 2
prognosis (2) 2
statins (2) 2
total cardiovascular risk (2) 2
treatment, adherence (2) 2
treatment, drugs (2) 2
treatment, lifestyle (2) 2
type-2 diabetes-mellitus (2) 2
14 randomized-trials (1) 1
3111 biomedicine (1) 1
abdominal aortic-aneurysm (1) 1
adherence (1) 1
anticholesteremic agents - administration & dosage (1) 1
anticholesteremic agents - therapeutic use (1) 1
apolipoprotein (1) 1
article (1) 1
atorvastatin (1) 1
azetidines - adverse effects (1) 1
azetidines - therapeutic use (1) 1
biomarkers - blood (1) 1
biomarkers - metabolism (1) 1
blood cholesterol (1) 1
blood flow velocity - drug effects (1) 1
blood pressure - drug effects (1) 1
blood-pressure (1) 1
brachial artery - physiology (1) 1
brachial-artery (1) 1
burden (1) 1
cardiac device (1) 1
cardiac imaging (1) 1
cardiac surgery (1) 1
cardiology and cardiovascular medicine (1) 1
cardiovascular (1) 1
cardiovascular agents - pharmacokinetics (1) 1
cardiovascular agents - pharmacology (1) 1
cardiovascular agents - therapeutic use (1) 1
cardiovascular diseases - chemically induced (1) 1
cardiovascular diseases - drug therapy (1) 1
cardiovascular diseases - etiology (1) 1
cardiovascular risk (1) 1
cardiovascular risk patients (1) 1
cardiovascular risk-factors (1) 1
cardiovascular-disease (1) 1
cholesterol ester transfer proteins - antagonists & inhibitors (1) 1
cholesterol levels (1) 1
cholesterol, hdl - metabolism (1) 1
cholesterol, ldl - drug effects (1) 1
cholesterol, ldl - metabolism (1) 1
clinical trials (1) 1
clinical trials as topic (1) 1
clinical trials;lipid-lowering drugs;lipoproteins;monoclonal antibodies;pcsk9 (1) 1
clinical-practice (1) 1
cohort studies (1) 1
computer applications to medicine. medical informatics (1) 1
congenital heart disease (1) 1
congenital heart-disease (1) 1
coronary disease - blood (1) 1
coronary disease - epidemiology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European heart journal, ISSN 0195-668X, 2015, Volume 36, Issue 44, pp. 3075 - +
Journal Article
by Leiter, L. A and Lundman, P and da Silva, P. M and xel, H and Jünger, C and Gitt, A. K and Absenger, Guun and Albrich, Ernst and Allinger, Berndt and Allinger, Stephan and Anacher, Gerald and Angermayr, Gertraud and Angermeier, Hermann and Anzengruber, Aneas and Archimanitis, Gabriele and Arnsteiner, Patricia and Auberger, Wolfgang and Azhary, Mawaheb and Barfuss, Michael and Bauer, Christian and Bauer, Birgit Elisabeth and Beclin, Thomas and Binder, Thomas and Binder, Gabriele and Böhler, Dietmar and Brändle, Johann and Breslmair, Jörg and Brettlecker, Marlis and Bürger, Michael and Calvi, Inge and Dorfinger, Werner and Doringer-Schnepf, Elisabeth and Eer, Anton and Eckmayr, Christine and Eder, Franz and Egermann, Margit and Erath, Michael and Etzinger, Michael and Etzinger, Claudia and Fiedler, Lothar and Filip, Wolfgang and Filip, Michaela and Föchterle, Johann and Fodor, Anita and Frieden, Thomas and Gareiss, Mertens and Gföllner, Peter and Ghamarian, Thomas and Goritschan, Michael and Haar, Klaus and Habeler, Gerhard and Hadjiivanov, Valery and Haiböck, Christian and Hammer, Regina and Hartmann, Siegfried and Haschkovitz, Herbert and Hauer, Walter and Hauer, Josef and Haunschmidt, Christian and Heimayr, Christine and Hengl, Wolfgang and Hengl, Gunter and Hermann, Rudolf and Herrmann, Rainer and Hillebrand, Roswitha and Hintersteininger, Otto and Hirsch, Michael and Hitzinger, Martin and Hochegger, Tanja and Hockl, Wolfgang and Hoi, Michael and Hörmann, Jan and Hudler, Brigitte and Imb, Gerhard and Joichl, Anea and Jungbauer, Karl and Kapl, Gerlinde and Kerschbaum, Margit and Kienesberger, Franz and Killinger, Gerhard and Kitzler, Gerhard and Klein, Franz and Kleinbichler, Dietmar and Kohr, Anton and Kopetzky, Michael and Korthals, Christian and Kortschak, Werner and Koschutnik, Martin and Kraus, Werner A and Kurzemann, Susanne and Lavicka, Claus and Lehner, Guido and Lenz, Jürgen and Lepuschütz, Sabine and Lichtenwallner, Michael and Lober, Reinhard and Loidl, Christine and Lopatka, Eduard and Ludwig, Rudolf and Maca, Thomas and ... and DYSIS Investigators and DYSIS investigators
Diabetic medicine, ISSN 0742-3071, 2011, Volume 28, Issue 11, pp. 1343 - 1351
To assess the prevalence of persistent lipid abnormalities in statin-treated patients with diabetes with and without the metabolic syndrome. This was a... 
metabolic syndrome | cardiovascular disease | diabetes mellitus | dyslipidaemia | statins | Cardiovascular disease | Dyslipidaemia | Metabolic syndrome | Diabetes mellitus | Statins | METAANALYSIS | GUIDELINES | PREVENTION | DENSITY-LIPOPROTEIN CHOLESTEROL | THERAPY | REDUCTION | ENDOCRINOLOGY & METABOLISM | CORONARY-HEART-DISEASE | CLINICAL-PRACTICE | CARDIOVASCULAR RISK | LOW HDL-CHOLESTEROL | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Humans | Diabetic Angiopathies - etiology | Male | Metabolic Syndrome - drug therapy | Diabetes Mellitus, Type 2 - epidemiology | Metabolic Syndrome - blood | Canada - epidemiology | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Female | Dyslipidemias - etiology | Diabetes Mellitus, Type 2 - complications | Metabolic Syndrome - epidemiology | Cardiovascular Diseases - etiology | Diabetic Angiopathies - chemically induced | Cross-Sectional Studies | Cholesterol, HDL - drug effects | Europe - epidemiology | Cholesterol, LDL - drug effects | Diabetic Angiopathies - blood | Anticholesteremic Agents - adverse effects | Metabolic Syndrome - complications | Diabetes Mellitus, Type 2 - blood | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Anticholesteremic Agents - administration & dosage | Dyslipidemias - chemically induced | Cholesterol, HDL - blood | Diabetic Angiopathies - epidemiology | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Diabetics | Blood cholesterol | Simvastatin | Low density lipoproteins | Triglycerides | Diabetes | Risk factors | Trans fatty acids
Journal Article